Journal profile · Biochemistry & Molecular Biology
Journal of Enzyme Inhibition and Medicinal Chemistry
ISSN 1475-6366 · eISSN 1475-6374 · Informa Healthcare · ENGLAND · Bimonthly · Founded 2002
Journal of Enzyme Inhibition and Medicinal Chemistry: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.29; JCR Q1 (journal website); fully open access; APC about USD 2,990; median 85 days to acceptance (102 articles, last 24 months); community-reported acceptance: easy; 112 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Enzyme Inhibition and Medicinal Chemistry is published by Informa Healthcare and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Synthesis and biological activity, Enzyme function and inhibition and Cholinesterase and Neurodegenerative Diseases, together about 35.9% of its articles. Its main subfields are Organic Chemistry and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research. The journal’s focus includes current developments in: Enzymology Cell biology Chemical biology Microbiology Physiology Pharmacology leading to drug design Molecular recognition processes Distribution and metabolism of biologically active compounds Across these fields of study, special attention is given to: Structure and molecular aspects Enzyme kinetics and inactivation mechanisms Structure-activity relationships (QSAR, graphic techniques) Drug development studies and drug release Control mechanisms in metabolic processes Journal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Commentaries and Editorials (Editors and Guest Advisors only) for publication. The journal operates a double anonymized peer review policy. Read the Instructions for Authors .
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief Binghe WangPublisher website
Editorial board by country: 2 in mainland China (about 50%); most named Mainland China 2, United States 1, Italy 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Synthesis and biological activityChemistry13.8%
- Enzyme function and inhibitionBiochemistry, Genetics and Molecular Biology12.5%
- Cholinesterase and Neurodegenerative DiseasesMedicine9.7%
- Synthesis and Catalytic ReactionsChemistry6.3%
- Computational Drug Discovery MethodsComputer Science5.9%
- Synthesis and Biological EvaluationChemistry5.8%
- Phenothiazines and Benzothiazines Synthesis and ActivitiesBiochemistry, Genetics and Molecular Biology5.3%
- Cancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Chemistry, Medicinal | Zone 2 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Index Medicus, Research Alert, SciSearch, BIOSIS, Biotechnology Citation Index, Elsevier BIOBASE/Current Awareness in Biological Sciences, Current Science Ltd, SIIC, Sheffield University Biomedical Information Services (SUBIS)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.29LetPub ·
- Impact factor (publisher) 2025
- 5.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.8Publisher website ·
- CiteScore 2026-06
- 11.9LetPub ·
- CiteScore (publisher) 2025
- 11.9Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SJR (publisher) 2025
- 0.78Publisher website ·
- SNIP 2026-06
- 1.19LetPub ·
- SNIP (publisher) 2025
- 1.19Publisher website ·
- h-index
- 61LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 2,425OpenAlex ·
- 2-year mean citedness
- 3.93OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 109LetPub ·
- Downloads per year (publisher)
- 1,100,000Publisher website ·
Articles by year OpenAlex count · 3,495 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 103 | 103 | 59 |
| 2025 | 112 | 112 | 483 |
| 2024 | 74 | 74 | 594 |
| 2023 | 196 | 196 | 3,228 |
| 2022 | 207 | 207 | 4,837 |
| 2021 | 192 | 192 | 5,235 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
85 daysMedian, submission to acceptance · P25–P75 66 days – 119 days
- Acceptance to online
- median 21 days (102 articles)
- Submission to online
- median 112 days
- Sample
- 102 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 37%Publisher website ·
- Submission to first decision
- 15 daysPublisher website ·
- First decision after review
- 25 daysPublisher website ·
- Acceptance to publication
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 26 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 4,165 / EUR 2,875 / GBP 2,392 / USD 2,990 | Yes | CC BY, CC BY-NC | |
| OpenAlex | GBP 1,880 | — | — | |
| LetPub | EUR 2,520 / USD 2,630 / GBP 2,100 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- article commentariesJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- brief reportsJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- data notesJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- editorials (editors and guest advisors only)Journal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- methodsJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- original articlesJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- reviewsJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
- systematic reviewsJournal of Enzyme Inhibition and Medicinal Chemistry accepts Original Articles, Reviews, Systematic Reviews, Methods, Brief Reports, Data Notes, Article Comment…Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Journal of Enzyme Inhibition and Medicinal Chemistry is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reac…
Source ↗Publisher website ·- Peer review
Double anonymized peer review policy Model summary
The journal operates a double anonymized peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1475-6366
- Electronic ISSN
- 1475-6374
- Latest issue on the website
- Volume 41, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Enzyme Inhibition and Medicinal Chemistry
What CAS zone is Journal of Enzyme Inhibition and Medicinal Chemistry in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Enzyme Inhibition and Medicinal Chemistry is in Zone 2 of Medicine, and in Zone 2 of the minor category Biochemistry & Molecular Biology / Chemistry, Medicinal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Enzyme Inhibition and Medicinal Chemistry?
The latest impact factor listed by LetPub is 5.29; CiteScore 11.9, h-index 108.
How long does peer review take at Journal of Enzyme Inhibition and Medicinal Chemistry?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 85 days (interquartile range 66–119 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 37%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Enzyme Inhibition and Medicinal Chemistry in?
The journal's website gives JCR Q1 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 2 of Medicine.
Where are the editorial board members of Journal of Enzyme Inhibition and Medicinal Chemistry based?
Of the 4 board members whose country the journal's board page names, 2 (about 50%) are in mainland China; the countries named most often are Mainland China (2), United States (1) and Italy (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Enzyme Inhibition and Medicinal Chemistry?
According to LetPub and DOAJ records, Journal of Enzyme Inhibition and Medicinal Chemistry is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Journal of Enzyme Inhibition and Medicinal Chemistry open access, and what is the APC?
Journal of Enzyme Inhibition and Medicinal Chemistry is a fully open-access journal. APC about USD 2,990.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .